top of page
AMGN v. Sanofi Ab Patent Case - What Biotech Investors Should Know
Amgen v. Sanofi Sup Ct. oral arguments took place yesterday in the ongoing PCSK9* antibody (Ab) patent case. See the attached transcript and FIG. 1. Who won the oral arguments? Verdict? Although it's hard to predict the outcome of the case from the oral arguments, I give the advantage in the orals to Sanofi Some of the Sup Ct justices don't like that AMGN's patent covers millions of antibodies (Abs) and only discloses 26 Abs And the fact that there is no structure, only funct
Mar 28, 20233 min read
Â
Â
Â


Free Biopharma Daily Pulse - 08/26/22
$XBI $85.04 | -4.85% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 26, 20221 min read
Â
Â
Â


Free Biopharma Daily Pulse - 08/26/22
$XBI $85.04 | -4.85% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 26, 20221 min read
Â
Â
Â


Biopharma Daily Stock Updates - 06/03/22
$XBI $71.21 | +3.55% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -20% Novavax Statement on...
Jun 3, 20222 min read
Â
Â
Â


Free Biopharma Daily Stock Updates - 06/03/22
$XBI $71.21 | +3.55% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -20% Novavax Statement on...
Jun 3, 20222 min read
Â
Â
Â
J.P. Morgan Healthcare Conference
The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...
Dec 31, 20212 min read
Â
Â
Â
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page
